Susquehanna Fundamental Investments’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,919
Closed -$646K 623
2025
Q4
$646K Sell
10,919
-2,270
-17% -$123K 0.02% 399
2025
Q3
$728K Sell
13,189
-9,710
-42% -$505K 0.03% 383
2025
Q2
$987K Sell
22,899
-10,100
-31% -$390K 0.03% 449
2025
Q1
$1.31M Buy
32,999
+13,697
+71% +$606K 0.02% 630
2024
Q4
$787K Buy
+19,302
New +$804K 0.01% 773
2023
Q2
Sell
-10,264
Closed -$734K 799
2023
Q1
$734K Sell
10,264
-21,569
-68% -$1.71M 0.02% 591
2022
Q4
$2.24M Sell
31,833
-2,243
-7% -$158K 0.04% 455
2022
Q3
$2.07M Buy
+34,076
New +$2.29M 0.04% 568
2022
Q1
$1.63M Buy
+25,421
New +$1.7M 0.03% 662
2021
Q4
Sell
-7,883
Closed -$563K 1662
2021
Q3
$563K Buy
+7,883
New +$622K 0.01% 1140
2021
Q2
Sell
-13,200
Closed -$997K 1730
2021
Q1
$997K Hold
13,200
0.02% 890
2020
Q4
$1M Hold
13,200
0.02% 865
2020
Q3
$653K Hold
13,200
0.02% 788
2020
Q2
$694K Buy
+13,200
New +$627K 0.03% 526

Other funds holding NGVT

Susquehanna Fundamental Investments's NGVT Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 10,919 shares — an estimated $646K sold.

Susquehanna Fundamental Investments first reported a position in NGVT in Q2 2020 and held it in 14 quarters. The position peaked at $2.24M in Q4 2022. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 10,919 Ingevity shares in Q1 2026, an estimated $646K.
  • Susquehanna Fundamental Investments first reported a position in Ingevity in Q2 2020 and held it in 14 quarters.
  • Susquehanna Fundamental Investments's Ingevity position peaked at $2.24M in Q4 2022.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.